Allyson Guidroz - 16 Feb 2025 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
Chief Accounting Officer
Signature
/s/ Jennifer Guckert Griffin, pursuant to a power of attorney
Issuer symbol
AMED
Transactions as of
16 Feb 2025
Net transactions value
-$23,520
Form type
4
Filing time
19 Feb 2025, 21:21:25 UTC
Previous filing
02 Aug 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +2,160 +24% $0.000000 11,056 16 Feb 2025 Direct F1
transaction AMED Common Stock Tax liability $23,520 -254 -2.3% $92.60 10,802 16 Feb 2025 Direct
holding AMED Common Stock 2 16 Feb 2025 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 2,160 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest 25% on each of February 16, 2026 and February 16, 2027 and 50% on February 16, 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The information in this report is based on a plan statement dated as of December 31, 2024.